These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12465010)

  • 21. Expression of pro-inflammatory protein, iNOS, VEGF and COX-2 in oral squamous cell carcinoma (OSCC), relationship with angiogenesis and their clinico-pathological correlation.
    Sappayatosok K; Maneerat Y; Swasdison S; Viriyavejakul P; Dhanuthai K; Zwang J; Chaisri U
    Med Oral Patol Oral Cir Bucal; 2009 Jul; 14(7):E319-24. PubMed ID: 19300368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR).
    Kroll J; Waltenberger J
    Biochem Biophys Res Commun; 1998 Nov; 252(3):743-6. PubMed ID: 9837777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of dendritic cell infiltration and vascular endothelial growth factor expression on the prognosis of non-small cell lung cancer.
    Inoshima N; Nakanishi Y; Minami T; Izumi M; Takayama K; Yoshino I; Hara N
    Clin Cancer Res; 2002 Nov; 8(11):3480-6. PubMed ID: 12429638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of vascular endothelial growth factor (VEGF) in normal oral mucosa, oral dysplasia and oral squamous cell carcinoma.
    Johnstone S; Logan RM
    Int J Oral Maxillofac Surg; 2007 Mar; 36(3):263-6. PubMed ID: 17141472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implication of vascular endothelial growth factor and p53 status for angiogenesis in noninvasive colorectal carcinoma.
    Kondo Y; Arii S; Furutani M; Isigami S; Mori A; Onodera H; Chiba T; Imamura M
    Cancer; 2000 Apr; 88(8):1820-7. PubMed ID: 10760758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between type II nitric oxide synthase and p53 expression in oral squamous cell carcinoma.
    Brennan PA; Palacios-Callender M; Umar T; Hughes D; Spedding AV; Zaki GA; Langdon JD
    Br J Oral Maxillofac Surg; 2000 Dec; 38(6):627-632. PubMed ID: 11092782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells.
    Ambs S; Merriam WG; Ogunfusika MO; Bennett WP; Ishibe N; Hussain SP; Tzeng EE; Geller DA; Billiar TR; Harris CC
    Nat Med; 1998 Dec; 4(12):1371-6. PubMed ID: 9846573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Correlation between expression of vascular endothelial growth factor and prognosis of patients with esophageal squamous cell carcinoma].
    Hu CZ; Wang YX; Zhang XZ
    Ai Zheng; 2002 Mar; 21(3):301-4. PubMed ID: 12452000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
    Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of vascular endothelial growth factor and microvessel density in head and neck tumorigenesis.
    Tae K; El-Naggar AK; Yoo E; Feng L; Lee JJ; Hong WK; Hittelman WN; Shin DM
    Clin Cancer Res; 2000 Jul; 6(7):2821-8. PubMed ID: 10914730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma.
    Zhang L; Yang N; Conejo-Garcia JR; Katsaros D; Mohamed-Hadley A; Fracchioli S; Schlienger K; Toll A; Levine B; Rubin SC; Coukos G
    Clin Cancer Res; 2003 Jan; 9(1):264-72. PubMed ID: 12538479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of inducible nitric oxide synthase results in reductions in wound vascular endothelial growth factor expression, granulation tissue formation, and local perfusion.
    Howdieshell TR; Webb WL; Sathyanarayana ; McNeil PL
    Surgery; 2003 May; 133(5):528-37. PubMed ID: 12773981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inducible nitric oxide synthase expression in human colorectal cancer: correlation with tumor angiogenesis.
    Cianchi F; Cortesini C; Fantappiè O; Messerini L; Schiavone N; Vannacci A; Nistri S; Sardi I; Baroni G; Marzocca C; Perna F; Mazzanti R; Bechi P; Masini E
    Am J Pathol; 2003 Mar; 162(3):793-801. PubMed ID: 12598314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microvessel density (MVD) and vascular endothelial growth factor expression (VEGF) in human oral squamous cell carcinoma.
    Artese L; Rubini C; Ferrero G; Fioroni M; Santinelli A; Piattelli A
    Anticancer Res; 2001; 21(1B):689-95. PubMed ID: 11299827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in human malignant melanoma and their relation to angiogenesis.
    Tu YT; Tao J; Liu YQ; Li Y; Huang CZ; Zhang XB; Lin Y
    Clin Exp Dermatol; 2006 May; 31(3):413-8. PubMed ID: 16681591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does expression of inducible nitric oxide synthase correlate with severity of oral epithelial dysplasia?
    Brennan PA; Palacios-Callender M; Sinclair D; Spedding AV; Zaki GA
    J Craniomaxillofac Surg; 2000 Feb; 28(1):44-8. PubMed ID: 10851673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between immunohistochemical expression of vascular endothelial growth factor (VEGF), VEGF-expressing neuroendocrine-differentiated tumor cells, and outcome in prostate cancer patients subjected to watchful waiting.
    Borre M; Nerstrøm B; Overgaard J
    Clin Cancer Res; 2000 May; 6(5):1882-90. PubMed ID: 10815911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) expression in superficial transitional cell bladder carcinoma].
    Guo ZH; Mei H; Huang J; Li SY
    Ai Zheng; 2003 Mar; 22(3):307-9. PubMed ID: 12654193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The expression of basic fibroblast growth factor and vascular endothelial growth factor in prostatic adenocarcinoma: correlation with neovascularization.
    Sugamoto T; Tanji N; Sato K; Fujita H; Nishio S; Sakanaka M; Yokoyama M
    Anticancer Res; 2001; 21(1A):77-88. PubMed ID: 11299793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.